Atalanta gets $97M boost to take two siRNAs into clinic for rare neuro disorders

For five years, Atalanta Therapeutics operated with one investor.

Now, F-Prime Capital is getting a bevy of financial support to propel two of the Boston …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Xlife Sciences AG Publishes 2023 Annual Report – Biotech Investments

Xlife Sciences AG / Key word(s): Annual Results 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

April 24, 2024

Spexis to host business update conference call on October 9, 2023 – Biotech Investments

Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST Spexis to host

October 7, 2023

The Health IT Needed to Implement Harris’ Medicare Home Care Proposal

Dharam Khalsa, Co-Founder of Assisted Living platform Mirador Vice President Harris’ proposal to expand Medicare to include home care for seniors and people with disabilities

December 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.